Compliance and Stewardship: Waste Reduction and Cost Savings

Opinion
Video

Health care providers discuss how prefilled syringes reduce diversion risks, enhance waste management, and offer cost-effective solutions, ensuring compliance with regulations.

This is a video synopsis/summary of a Practice Pearls featuring Ryan Haumschild, PharmD, MS, MBA, CPEL; Megan Mitchell, PharmD, MS; Stephanie Abel, PharmD, BCPS; and Jennifer Grate, CPhT.

Haumschild leads a comprehensive discussion on prefilled syringes, waste management, and diversion risk with Grate. Haumschild emphasizes the importance of evaluating care locations and total cost considerations beyond product costs. Grate discusses diversion risks, highlighting vial-related challenges, such as overfill diversion opportunities and concealment ease. She contrasts this with prefilled syringes, emphasizing reduced waste and syringe visibility, minimizing diversion risks. As the conversation shifts to waste management, Grate outlines best practices for prefilled syringe disposal, emphasizing irretrievability and proper pharmaceutical destruction. She recommends using designated containers for controlled substances, debunking the use of sharps containers. Haumschild acknowledges the impact on waste reduction and the importance of adhering to guidelines. Grate emphasizes the safety and effectiveness of utilizing sharps containers for syringe disposal. The discussion concludes with insights into reducing waste frequency and implementing efficient waste disposal practices.

This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.

Related Videos
Video 14 - "Closing Remarks on RSV Vaccinations"
Video 13 - "Understanding RSV Infection Patterns and Seasonal Outbreaks"
Video 12 - "Empowering RSV Patients: Essential Vaccine Education Resources"
Video 11 - "Unmet Needs in Prevention and Management of RSV"
Video 12 - "Collaborative Care: Key Stakeholders in HE Treatment and Recovery"
Video 11 - "Optimizing Transitions of Care for Hepatic Encephalopathy Patients"
Video 10 - "Valuable Metrics and Improving Adherence in Patients With ASCVD"
Video 9 - "The Role of Pharmacists in Treating Very High-Risk ASCVD"
Video 6 - "evaluating CDK4/6 inhibitor safety profiles"
Video 5 - "CDK4/6 Inhibitor Sequencing and NCCN Guidelines in mBC"
Related Content
© 2024 MJH Life Sciences

All rights reserved.